SCHEMBL13560958

SCHEMBL13560958

CCC[C@H](NC(=O)OC(C)(C)C)C(=O)OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
HTT P42858 1/20 0.61
CTSK P43235 10/20 0.58
CTSS P25774 4/20 0.58
SMN1; SMN2 Q16637 1/20 0.52
ALDH1A1 P00352 3/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46
ALOX12 P18054 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14483921 1.00 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL29508434 1.00 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL17369162 0.90 CTSK (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL16379313 0.90 CTSK (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL17449759 0.90 CTSK (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7308713 0.89 CYP1A2 (0.59) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL29399499 0.89 CYP1A2 (0.59) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL18082612 0.88 CTSK (0.60) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL5040904 0.88 CTSK (0.60) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL18130977 0.88 CTSK (0.60) CYP1A2CYP2C9CYP2C19HTTCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2517706-A2 Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof Bristol-Myers Squibb Company (US) 2012-10-31 EP disclosed